News
Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells. PNAS . 2024;121(3):e2315857121. doi: 10.1073/pnas.2315857121 This ...
7mon
Live Science on MSNCan viruses cause cancer?So which viruses can cause cancer, and how do they do it? There are at least seven viruses that are known to contribute to ...
Investigating the potential of EBV T cells. Looking at the overall landscape for MS therapeutics, we learned over time about the important role of T and B cells in this disease.
Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today provided an update on its ongoing development of a ...
LENEXA, Kan., Oct. 3, 2022 /PRNewswire/ -- Eurofins Viracor, a leader in infectious disease and immunology testing, launches EBV inSIGHT™, a functional T Cell test to measure CD4 and CD8 Epstein ...
The body's immune response to Epstein-Barr virus (EBV) may play a role in causing damage in people with multiple sclerosis, according to a new study led by University of Texas Health Houston.
The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: two new developments in the EBV field. Adv Cancer Res 1993;62:179-239. Crossref. PubMed.
Study: Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells.Image Credit: 3d_man / Shutterstock. Now, research led ...
Venlo, the Netherlands, Oct. 04, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its QuantiFERON-EBV RUO (Research Use Only) assay ...
Organically Human on MSN2mon
MS reversed by transplanted immune cells that fight Epstein-Barr virusA new study found that part of the Epstein-Barr virus mimics a protein made in the brain and spinal cord, leading the immune ...
Harnessing EBV-specific T cells. At least 95% of adults 40 years and older have been infected with the Epstein-Barr virus (EBV). In most people infected with EBV, ...
T cell therapy, zilovertamab vedotin in relapsed or refractory (R/R) LBCL, and optimal dosing of AFM13 plus AlloNK in R/R ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results